Page 15 - Sohini Das

IIT-B startup HaystackAnalytics plans to take genome testing to EU, US

Srivastava says that in the next five years they need to invest another $40-50 million or so to build the business, and there are plans to take the infexn test to the US and Europe as well

Aveo Pharma suspects misuse of painkiller Tafrodol in importing countries

The company also clarified that the "stop production" order of Feb 24 was due to compliance issues under the Schedule M of the Drugs and Cosmetics Rules, 1945, and not due to the combination product

Hyundai's Rs 31,526 crore related-party transactions under scrutiny

Proxy advisory firms divided over supporting the transactions

Carmakers dangle deep discounts to lure buyers back into showrooms

Benefits in March range from Rs 35,000-4 lakh price cuts on various models

Tesla entering India with much fanfare but latter a challenging mkt for EVs

The potential impact on domestic EV manufacturers, government policies, and the broader market also remain subjects of speculation

Eliminate import duty on drugs from US: Pharma exporters to Centre

The exporters' worry is understandable as the US is the largest export market for Indian pharma accounting for 31.35 percent of India's overall pharma exports worth $27.8 bn

Ultraviolette hits the gas, to come out with 10 new e 2-wheelers in 3 years

At present they can make 10,000 two-wheelers a year, easily scalable up to 30,000 units a year in three shifts

Metropolis strengthens UP presence with acquisition of Scientific Pathology

The move aims to strengthen Metropolis' position in the western Uttar Pradesh market where Scientific Pathology has a strong presence

Luxury cars, electric vehicles hit fast lane in the South as demand rises

In 2024 alone, South India saw the highest rise in sales in the luxury segment, with Tamil Nadu reportedly registering a 19.3 per cent increase in premium car registrations from 2022-23

Distributed manufacturing may become the future trend: Pharma Inc

Volumes need to be high to justify relocation of manufacturing; strategic decisions cannot be based on current tariff structure

Mankind Pharma sets sights on Novo Nordisk's anti-obesity drug Semaglutide

The firm is focusing on specialty chronic therapies like immunotherapy, antibody-drug conjugates, and gene therapy drugs, besides peptides like Glucagon-like peptide-1 (GLP-1)

Tesla must price India models competitively as buzz around entry grows

Tesla has also ended its true low-cost Model 2 efforts a year ago, shifting its focus to robotaxi and robotics plans

Creditors greenlight two-wheeler maker KTM AG debt restructuring plan

KTM AG filed for court restructuring proceedings with self-administration on November 29, 2024

Venus Remedies to co-develop antibiotic resistance blocker with UK firm

Clinical trials to start next year, and drug can be in market by 2031-32

Biological E teams with Danish vax firm to give Chikungunya jabs to LMICs

The manufacturing agreement is to provide Chikungunya Vaccine to low-and middle-income countries

Our farm machinery sales to hit Rs 1,000 cr in FY25: M&M's Hemant Sikka

We are clearly seeing this macro trend play out over the last 15-20 years

KKR picks up 54% stake in cancer hospital chain HCG for Rs 3,465 crore

PE firm to make open offer to buy additional 26% for Rs 1,600 cr

Tesla entry not a major threat to electric vehicle OEMs, says CLSA

Even if Tesla launches a BEV at $25,000, CLSA feels that features and specifications would be 'meaningfully compromised' compared to its traditional models

Tesla's hunt for a factory site in India takes it to Andhra Pradesh

State has likely offered pre-acquired land at three potential locations

Kinetic's EV component biz will be up to Rs 1.5K cr in 4 years: Firodia

Firodia talked about his plans for the EV-components business, and the components business at large for the group